Abstract:Khaled S Allemailem, 1 Ahmad Almatroudi, 1 Arshad Husain Rahmani, 1 Faris Alrumaihi, 1 Arwa Essa Alradhi, 2 Amal M Alsubaiyel, 3 Mohammad Algahtani, 4 Rand Mohammad Almousa, 5 Ali Mahzari, 6 Abdulmajeed AA Sindi, 7 Gasim Dobie, 8 Amjad Ali Khan 9 1 Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia; 2 General Administration for Infectious Disease Control, Ministry of Health, Riyadh 12382, Saudi Arabia; 3 Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia; 4 Department of Laboratory & Blood Bank, Security Forces Hospital, Mecca 21955, Saudi Arabia; 5 Department of Education, General Directorate of Education, Qassim 52361, Saudi Arabia; 6 Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65527, Saudi Arabia; 7 Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65527, Saudi Arabia; 8 Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Gizan 82911, Saudi Arabia; 9 Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia Correspondence: Amjad Ali Khan, Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah, 51452, Saudi Arabia, Email The genome editing approach by clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (CRISPR/Cas9) is a revolutionary advancement in genetic engineering. Owing to its simple design and powerful genome-editing capability, it offers a promising strategy for the treatment of different infectious, metabolic, and genetic diseases. The crystal structure of Streptococcus pyogenes Cas9 (SpCas9) in complex with sgRNA and its target DNA at 2.5 Å resolution reveals a groove accommodating sgRNA:DNA heteroduplex within a bilobate architecture with target recognition (REC) and nuclease (NUC) domains. The presence of a PAM is significantly required for target recognition, R-loop formation, and strand scission. Recently, the spatiotemporal control of CRISPR/Cas9 genome editing has been considerably improved by genetic, chemical, and physical regulatory strategies. The use of genetic modifiers anti-CRISPR proteins, cell-specific promoters, and histone acetyl transferases has uplifted the application of CRISPR/Cas9 as a future-generation genome editing tool. In addition, interventions by chemical control, small-molecule activators, oligonucleotide conjugates and bioresponsive delivery carriers have improved its application in other areas of biological fields. Furthermore, the intermediation of physical control by using heat-, light-, magnetism-, and ultrasound-responsive elements attached to this molecular tool has revolutionized genome editing further. These strategies significantly reduce CRISPR/Cas9's undesirable off-target effects. However, other undesirable effects still offer some challenges for comprehensive clinical translation using this genome-editing approach. In this review, we summarize recent advances in CRISPR/Cas9 structure, mechanistic action, and the role of small-molecule activators, inhibitors, promoters, and physical approaches. Finally, off-target measurement approaches, challenges, future prospects, and clinical applications are discussed. Keywords: CRISPR/Cas9, sgRNA, genome editing, off-target effects, spatiotemporal control, clinical translation Clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (CRISPR/Cas9) are a class of microbial defense mechanisms against mobile genetic elements, plasmids, and phage infections. 1,2 This endonuclease system has been proposed as an innovative tool for genome editing, genome imaging, epigenetic modulation, and transcriptional perturbation. The genome editing technology by using CRISPR/Cas9 is used to precisely manipulate functional genes involved in disease progression, correct disease-initiating mutations, activate tumor suppressor genes, and inactivate activated oncogenes. 3–5 CRISPR/Cas9 technology can be used to treat a variety of infectious and genetic diseases such as metabolic disorders, cardiovascular diseases, Alzheimer's disease, and human immunodeficiency virus (HIV) infections, 6,7 because of its simple design and ability to simultaneously edit multiple sites. 8 Other DNA editing approaches such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) are also used for -Abstract Truncated-

Modulating CRISPR/Cas9 genome-editing activity by small molecules

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Research Progress of CRISPR-Cas9 Functional Regulation System Based on Small Molecule Reaction Tools

Infarct volume varies with rat strain and vendor in focal cerebral ischemia induced by transcranial middle cerebral artery occlusion

Spatiotemporal control of CRISPR/Cas9 gene editing

Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening.

Chemical Modification and Transformation Strategies of Guide RNAs in CRISPR‐Cas9 Gene Editing Systems

Improving transgene expression and CRISPR-Cas9 efficiency with molecular engineering-based molecules

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

KPT330 improves Cas9 precision genome- and base-editing by selectively regulating mRNA nuclear export

Molecular simulations have boosted knowledge of CRISPR/Cas9: A Review

CRISPR-Cas systems for editing, regulating and targeting genomes

Screening DNA Aptamers That Control the DNA Cleavage, Homology-Directed Repair, and Transcriptional Regulation of the CRISPR-(d)Cas9 System.

Advances in miniature CRISPR-Cas proteins and their applications in gene editing

The application of CRISPR /Cas mediated gene editing in synthetic biology: Challenges and optimizations

A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene Regulation

AMPA-selective glutamate receptor subunits and their relation to glutamate-and GABA-like immunoreactive terminals in the nucleus submedius of the rat

Programmable downsizing of CRISPR-Cas9 activity for precise and safe genome editing

Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies

Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing

CRISPR/Cas9 in Genome Editing and Beyond